Viralgen welcomes back Andy Holt as CCO
October 19, 2023 08:00 ET
|
Viralgen Vector Core
SAN SEBASTIAN, Spain, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Viralgen Vector Core (Viralgen) is pleased to welcome back their previous Executive Vice President of Commercial Development and...
Viralgen Vector Core and Elpida Therapeutics partner to manufacture gene therapy medicines for anticipated Spastic Paraplegia 50 (SPG50) and Charcot-Marie-Tooth disease type 4J (CMT4J) clinical trials
September 28, 2023 08:42 ET
|
Viralgen Vector Core
SAN DIEGO, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Viralgen Vector Core (Viralgen) and Elpida Therapeutics (Elpida Tx) have partnered to manufacture gene therapies for use in clinical trials sponsored by...